HC Wainwright & Co. Reiterates Buy on CytoSorbents, Maintains $5.5 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Sean Lee has reiterated a 'Buy' rating on CytoSorbents (NASDAQ:CTSO) and maintained a price target of $5.5.
August 04, 2023 | 10:48 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CytoSorbents' stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $5.5.
The reiteration of the 'Buy' rating and maintained price target by HC Wainwright & Co. indicates their continued confidence in CytoSorbents. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100